BERNINI, Franco
 Distribuzione geografica
Continente #
NA - Nord America 12.355
AS - Asia 11.647
EU - Europa 8.550
SA - Sud America 1.867
AF - Africa 568
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 11
Totale 35.013
Nazione #
US - Stati Uniti d'America 12.017
SG - Singapore 4.939
CN - Cina 3.738
IE - Irlanda 1.634
BR - Brasile 1.490
FI - Finlandia 1.285
DE - Germania 1.167
SE - Svezia 1.161
HK - Hong Kong 1.013
IT - Italia 950
UA - Ucraina 908
VN - Vietnam 756
TR - Turchia 539
ZA - Sudafrica 455
NL - Olanda 448
CA - Canada 232
GB - Regno Unito 230
RU - Federazione Russa 202
FR - Francia 177
AR - Argentina 162
IN - India 121
AT - Austria 104
BD - Bangladesh 86
IQ - Iraq 67
ID - Indonesia 63
JP - Giappone 63
EC - Ecuador 62
MX - Messico 61
KR - Corea 55
PL - Polonia 55
BE - Belgio 48
CZ - Repubblica Ceca 47
CO - Colombia 44
ES - Italia 35
VE - Venezuela 34
PK - Pakistan 30
UZ - Uzbekistan 28
PY - Paraguay 26
MA - Marocco 21
CL - Cile 18
EG - Egitto 16
SA - Arabia Saudita 16
CI - Costa d'Avorio 15
EU - Europa 15
IL - Israele 14
KE - Kenya 14
AE - Emirati Arabi Uniti 13
AL - Albania 13
IR - Iran 13
PE - Perù 13
JO - Giordania 12
KZ - Kazakistan 12
LT - Lituania 11
RO - Romania 11
UY - Uruguay 11
TW - Taiwan 10
TN - Tunisia 9
AU - Australia 8
MY - Malesia 8
TT - Trinidad e Tobago 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
ET - Etiopia 7
HU - Ungheria 7
NP - Nepal 7
KW - Kuwait 6
PA - Panama 6
RS - Serbia 6
BY - Bielorussia 5
CH - Svizzera 5
HN - Honduras 5
KG - Kirghizistan 5
LB - Libano 5
TH - Thailandia 5
AZ - Azerbaigian 4
BB - Barbados 4
BO - Bolivia 4
LU - Lussemburgo 4
NG - Nigeria 4
OM - Oman 4
PT - Portogallo 4
CM - Camerun 3
CR - Costa Rica 3
DK - Danimarca 3
GR - Grecia 3
JM - Giamaica 3
MD - Moldavia 3
MK - Macedonia 3
SI - Slovenia 3
SN - Senegal 3
AO - Angola 2
BW - Botswana 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
KI - Kiribati 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
Totale 34.976
Città #
Singapore 2.351
Dublin 1.634
Chandler 1.551
Ashburn 1.177
Jacksonville 1.115
Beijing 1.045
Hong Kong 1.000
Santa Clara 864
Dallas 605
Boardman 527
Nanjing 508
Dearborn 498
Izmir 484
Johannesburg 428
Princeton 388
Ann Arbor 376
New York 315
Parma 289
Ho Chi Minh City 285
Wilmington 260
Munich 239
San Mateo 234
Bremen 230
Los Angeles 200
Hefei 180
Helsinki 171
Shanghai 162
Toronto 157
Shenyang 154
Hanoi 152
Nanchang 137
Hebei 134
São Paulo 133
Moscow 125
Kunming 118
Columbus 106
Jinan 98
Seattle 98
Tianjin 93
Des Moines 92
Vienna 90
Buffalo 80
Jiaxing 78
Woodbridge 74
Grafing 73
Changsha 69
Council Bluffs 67
Guangzhou 62
Chicago 59
Marseille 59
Norwalk 57
Seoul 55
The Dalles 46
Zhengzhou 46
Brussels 45
Warsaw 45
Turku 44
Haiphong 43
Houston 43
Brooklyn 40
Tokyo 40
Milan 37
Pune 37
Rio de Janeiro 37
Belo Horizonte 36
Bologna 35
San Jose 34
Hangzhou 32
Jakarta 32
Montreal 31
Rome 31
Fremont 29
Brno 28
Denver 26
Taiyuan 26
Biên Hòa 25
Brasília 25
Phoenix 25
Atlanta 24
Curitiba 24
San Francisco 24
Tashkent 24
Chennai 23
Guayaquil 23
Orem 23
Stockholm 23
Düsseldorf 21
Hải Dương 21
Nuremberg 21
Baghdad 20
Modena 20
Quito 20
Frankfurt am Main 19
Haikou 19
London 19
Bengaluru 18
Manchester 18
Boston 17
Da Nang 17
Mexico City 17
Totale 20.909
Nome #
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 298
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 229
The adaptation of lipid profile of human fibroblasts to alginate 2D films and 3D printed scaffolds 209
Three-Dimensional (3D) Printed Silver Nanoparticles/Alginate/Nanocrystalline Cellulose Hydrogels: Study of the Antimicrobial and Cytotoxicity Efficacy 201
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 187
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease 186
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 185
Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis 179
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 171
Advance diagnostic support in lipidology project: role for phenotipic and functional evaluation of lipoproteins in dyslipidemias 163
ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects 154
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 153
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 151
Highly defined 3D printed chitosan scaffolds featuring improved cell growth 149
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 148
Biocompatible 3d printed chitosan-based scaffolds containing α-tocopherol showing antioxidant and antimicrobial activity 146
Attivita' del Probucolo nell'inibire l'efflusso lipidico cellulare ABCA1-mediato 146
Assessment of Cholesterol Efflux Potential of High-Density Lipoprotein after Treatment with Niacin Extended-Release or Fenofibrate 145
Antiatherogenic effects of ellagic acid and urolithins in vitro 145
Anti-atherogenic modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study 143
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) GENETIC DELETION ATTENUATES AMYLOID-. PATHOLOGY, NEUROINFLAMMATION AND IMPROVES COGNITIVE FUNCTIONS IN AN ALZHEIMER'S DISEASE MOUSE MODEL 139
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 137
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 136
Effetto delle statine sull’efflusso ABCA1 in macrofagi e cellule epatiche 133
Role of Apolipoprotein E in cellular cholesterol efflux 132
ABCA1 MODULATES CELLULAR MIGRATION AND MEMBRANE RUFFLING INDUCED BY FREE CHOLESTEROL IN MACROPHAGES FOAM CELLS 130
New MDR1 inhibitors for overcoming multidrug resistance 130
Effects of moderate and excess alcohol consumption on the reverse cholesterol transport in vivo 129
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 129
Ruolo dell’apolipoproteine E nell’efflusso cellulare di colesterolo 128
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G>C mutation in ABCA1 gene 127
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 126
CHARACTERIZATION OF THREE KINDRED WITH FAMILIAL COMBINED HYPOLIPIDEMIA DUE TO LOSS OF FUNCTION MUTATIONS OF ANGPTL3 126
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 126
Study of 3D-printed chitosan scaffold features after different post-printing gelation processes 125
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 124
Cellular cholesterol efflux pathways: Impact on Intracellular Lipid Trafficking and Methodological Considerations 124
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM DIABETIC PATIENTS: CLINICAL APPLICATIONS 124
Cholesterol efflux and reverse cholesterol transport 123
A NOVEL MUTATION IN CETP GENE AS A CAUSE OF CETP DEFICIENCY IN A CAUCASIAN KINDRED 123
Immunoglobulin G inhibit endothelial activation induced by atherogenic stimuli 122
Effect of vitamin D deficiency and replacement on serum HDL cholesterol efflux capacity in premenopausal women 122
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 121
A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux 121
Analysis of lipid efflux in fibroblasts from Niemann Pick Type C disease subjects 121
Cholesterol efflux capacity of sera from subjects with LCAT deficiency 120
Opposite effects of moderate and excess alcohol consumption on the atheroprotective process of the reverse cholesterol transport in vivo 120
Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages 119
Cholesterol efflux potential of sera from subjects with LCAT deficiency 119
Dietary Ellagitannin Metabolites Exert Antiatherosclerotic Effects in Vitro 119
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 119
Hydrocortisone directly promotes cholesterol accumulation in macrophages. 119
5,6-diphenylpyridazine derivatives as acyl-Coacholesterol acyltransferase inhibitors 118
CHOLESTEROL EFFLUX AND CHOLESTEROL LOADING CAPACITY OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 118
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 118
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 118
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 117
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFFNESS IN HEALTHY SUBJECTS 117
Cholesterol efflux capacity and arterial stiffness: data from the brisighella heart study 116
Functional pasta consumption in healthy volunteers modulates ABCG1-mediated cholesterol efflux capacity of HDL 116
Effect of carvedilol on cholesterol esterification and nitric oxide synthesis in cultured macrophages 115
New mechanisms for steroid pro-atherogenic action: up regulation of macrophage LDL receptors, down regulation of cholesterol efflux transporters and increase in intracelluar cholesterol stores. 115
CHOLESTEROL EFFLUX POTENTIAL OF SERA FROM PATIENTS BEFORE AND AFTER LDL-APHERESIS 115
Lercanidipine Reduces Free Cholesterol-Induced Cytotoxicity 115
Attivita’ del probucolo nell’inibire l’efflusso lipidico cellulare ABCA1 mediato 114
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 114
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 114
Cyclosporine a affects the reverse cholesterol transport from macrophages in vivo 114
RUOLO DELLA SFINGOSINA 1-FOSFATO E DEL SUO RECETTORE S1P3 NEL TRASPORTO INVERSO DEL COLESTEROLO 114
Influence of APOE4 genotype on PCSK9-lipids association in cerebrospinal fluid and serum of patients in the Alzheimer's disease continuum 113
The c-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phopspholipid and cholesterol efflux 113
Probucol inhibits ABCA1-mediated cellular lipids efflux 113
EFFECT OF VITAMIN D REPLACEMENT ON SERUM LIPOPROTEIN FUNCTIONALITY IN HEALTHY PRE-MENOPAUSAL WOMEN 113
SERUM CHOLESTEROL EFFLUX CAPACITY INVERSELY CORRELATES WITH ARTERIAL STIFNESS IN HEALTY SUBJECTS 113
Dislipidemia diabetica e spessore medio-intimale, ruolo del trasporto inverso del colesterolo. 113
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 113
Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women 113
A novel homozigous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 112
ANTIATHEROSCLEROTIC EFFECTS OF A NEW COMBINATION OF BERBERINE, MONACOLIN K AND MORUS ALBA: IMPROVEMENT OF HDL FUNCTION 112
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 112
Natural anti-endothelial cell antibodies (AECA) 111
Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells 111
An w-3 polyunsaturated fatty acid concentrate increases plasma HDL2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia 109
CHOLESTEROL EFFLUX CAPACITY, HDL-C LEVELS AND CORONARY CALCIUM SCORE AMONG THE VERY ELDERLY SUBJECTS 108
New insights into the pharmacodynamic and pharmacokinetic properties of statins 107
CAPACITA' DI EFFLUSSO DI COLESTEROLO (CEC): INDICE DI ATTIVITA' ATEROPROTETTIVA DELLE HDL? Cholesterol efflux capacity (CEC): an index of atheroprotective activity of HDL? 107
Depletion of Pre-{beta}-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein 107
Lacidipine modulates the secretion of matrix metalloproteinase-9 by human macrophages 106
Effect of an innovative pasta enriched with bioactive components and functional probiotics on HDL cholesterol efflux capacity 106
27-Hydroxycholesterol modulation of low density lipoprotein metabolism in cultured human hepatic and extrahepatic cells 106
6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells. 106
ATTIVITA’ IPOLIPIDEMIZZANTE DEL NUTRACEUTICO OLEACTIV® NEL MODELLO DEL CRICETO GOLDEN SYRIAN 106
Natural anti-endothelial cell antibodies (AECA) 105
Pitavastatin Differently Modulates ATP Binding Cassette A1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 105
Cellular toxicity of 2,2'N-dicarboxamidodiphenylsulphides with high antimicrobal activity 105
Evaluation of HDL cholesterol efflux capacity (CEC) after consumption of an innovative pasta enriched with bioactive components and functional probiotics 105
IN VIVO ACUTE SYSTEMIC INFLAMMATION, INDEPENDENTLY ON THE ETIOLOGY, AFFECTS HDL CHOLESTEROL EFFLUX CAPACITY 105
Impaired ATP-binding cassette Transporter AI-mediated Sterols Efflux from Oxidized LDL Loaded Macrophages 104
Fu5AH express functional ABCA1 upon treatment with 22OH-cholesterol and cis-9 retinoic acid 104
Immunoglobulins G inhibit endothelial activation induced by atherogenic stimuli 104
Totale 12.836
Categoria #
all - tutte 134.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.251 0 0 0 0 0 57 225 51 498 59 305 56
2021/20221.594 46 17 13 58 36 95 185 211 92 151 81 609
2022/20236.014 702 447 306 439 738 672 54 332 2.042 42 177 63
2023/20242.168 126 244 66 73 151 603 122 157 49 82 157 338
2024/20257.487 137 454 533 428 762 711 229 336 966 732 582 1.617
2025/20268.947 1.262 1.575 1.738 1.283 2.356 733 0 0 0 0 0 0
Totale 35.574